John P. Dekker
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 35
-
- Antibiotic Use and Resistance 11
- Endocrinology top 0.5%
- Vibrio bacteria research studies 10
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 23
-
- Genomics and Phylogenetic Studies 16
-
- Mycobacterium research and diagnosis 6
- Pneumonia and Respiratory Infections 6
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Karen M. FrankGary YellenAnna F. LauSameer S. KadriRobert L. DannerChanu RheeMichael KlompasTara N. Palmore
- Partner nations
- United StatesFranceBrazil
In The Last Decade
John P. Dekker
81 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Molecular Medicine 1.5k
- Applied Microbiology and Biotechnology 508
- Endocrinology 594
- Clinical Biochemistry 712
- Critical Care and Intensive Care Medicine 166
Countries citing papers authored by John P. Dekker
This map shows the geographic impact of John P. Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Dekker more than expected).
Fields of papers citing papers by John P. Dekker
This network shows the impact of papers produced by John P. Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Dekker. The network helps show where John P. Dekker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John P. Dekker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 22 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 11 | |
| 8 | 2020 | 7 | |
| 9 | Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Usebreakdown → | 2020 | 232 |
| 10 | 2020 | 55 | |
| 11 | 2019 | 14 | |
| 12 | 2018 | 22 | |
| 13 | 2018 | 141 | |
| 14 | 2018 | 41 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 6 | |
| 17 | 2017 | 21 | |
| 18 | 2012 | 51 | |
| 19 | 2006 | 40 | |
| 20 | 2004 | 175 |
About John P. Dekker
John P. Dekker is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 85 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), Bacterial Identification and Susceptibility Testing (23 papers), Genomics and Phylogenetic Studies (16 papers), Antibiotic Use and Resistance (11 papers), Vibrio bacteria research studies (10 papers), Mycobacterium research and diagnosis (6 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Applied Microbiology and Biotechnology (508 citations) and Endocrinology (594 citations). John P. Dekker has collaborated with scholars based in United States, France and Brazil. Frequent co-authors include Karen M. Frank, Gary Yellen, Anna F. Lau, Sameer S. Kadri, Robert L. Danner, Chanu Rhee, Michael Klompas, Tara N. Palmore, Susu He and Fred Dyda. Their work appears in journals such as Nature, New England Journal of Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.